The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology

URL:  http://boards.fool.com/also-any-choices-from-shuksan-sarah-missash-28191983.aspx

Subject:  Re: Biotech 2010 list so far Date:  12/29/2009  1:21 PM
Author:  SarahGen Number:  23841 of 25063

Also, any choices from shuksan? sarah? missash? CSOakes? Wadigo? Gillett? Applefoot? beautifulplumage? DavidMN? DartthrowingMonkey?


I'm still combing through ideas. :) But I'm sure about one (second to come soon).

I'll take Optimer (OPTR).

C-Diff hasn't been capturing headlines lately, but doesn't mean it won't later in 2010. Quite a journey from just a year or so ago when there was talk about sending some nurses and docs to jail for their roles in spreading it in Scotland.

Watching for: partnerships plus second phase 3 for Fidaxomicin - due to report data in early 2010.
If the second trial is as successful as the first trial, we intend to use these studies to support the filing of a new drug application, or NDA, for U.S. registration as soon as practical thereafter.
http://www.optimerpharma.com/pipeline.asp?pipeline=1

From my picks last year - SQNM worked out well, but I'm not sure it has as much juice left. ARRY - ehh - not again.

I'll be back with a second one. Thanks!

Sarah
Copyright 1996-2018 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us